[go: up one dir, main page]

AU2003251513A1 - Rsk inhibitors and therapeutic uses thereof - Google Patents

Rsk inhibitors and therapeutic uses thereof

Info

Publication number
AU2003251513A1
AU2003251513A1 AU2003251513A AU2003251513A AU2003251513A1 AU 2003251513 A1 AU2003251513 A1 AU 2003251513A1 AU 2003251513 A AU2003251513 A AU 2003251513A AU 2003251513 A AU2003251513 A AU 2003251513A AU 2003251513 A1 AU2003251513 A1 AU 2003251513A1
Authority
AU
Australia
Prior art keywords
therapeutic uses
rsk inhibitors
rsk
inhibitors
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003251513A
Other versions
AU2003251513A8 (en
Inventor
David L. Brautigan
Sidney M. Hecht
Deborah A. Lannigan-Macara
Celeste E. Poteet-Smith
Jeffrey A. Smith
Yaming Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UVA Licensing and Ventures Group
Original Assignee
University of Virginia UVA
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA, University of Virginia Patent Foundation filed Critical University of Virginia UVA
Publication of AU2003251513A1 publication Critical patent/AU2003251513A1/en
Publication of AU2003251513A8 publication Critical patent/AU2003251513A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003251513A 2002-06-12 2003-06-12 Rsk inhibitors and therapeutic uses thereof Abandoned AU2003251513A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38800602P 2002-06-12 2002-06-12
US60/388,006 2002-06-12
US44955303P 2003-02-24 2003-02-24
US60/449,553 2003-02-24
PCT/US2003/018734 WO2003105766A2 (en) 2002-06-12 2003-06-12 Rsk inhibitors and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
AU2003251513A1 true AU2003251513A1 (en) 2003-12-31
AU2003251513A8 AU2003251513A8 (en) 2003-12-31

Family

ID=29739979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003251513A Abandoned AU2003251513A1 (en) 2002-06-12 2003-06-12 Rsk inhibitors and therapeutic uses thereof

Country Status (4)

Country Link
EP (1) EP1539781A4 (en)
AU (1) AU2003251513A1 (en)
CA (1) CA2488864A1 (en)
WO (1) WO2003105766A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920393D0 (en) 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
KR100590818B1 (en) 2004-10-11 2006-06-19 재단법인서울대학교산학협력재단 Prevention and Treatment of Diabetes, Obesity and Metabolic Syndrome by Directly Enhancing 활성 90 Ribosome S6 Kinase 1 (RSS1) Activity of Small-Molecular Organic Compounds
CA2594542C (en) * 2005-01-10 2014-03-25 University Of Virginia Patent Foundation Synthesis of inhibitors of p90rsk
WO2006132401A1 (en) * 2005-06-07 2006-12-14 Banyu Pharmaceutical Co., Ltd. Method for evaluation of compound using rsk1
GB0512206D0 (en) 2005-06-15 2005-07-27 Biosynth As Synthesis
US7659313B2 (en) * 2007-09-13 2010-02-09 Gateway Health Alliances, Inc. Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
GB0718870D0 (en) * 2007-09-27 2007-11-07 Univ Dundee Modulation of RSK
WO2011019995A2 (en) 2009-08-14 2011-02-17 Hecht Sidney M Synthesis and identification of novel rsk-specific inhibitors
CA2913583C (en) * 2012-06-04 2019-08-06 Phoenix Molecular Diagnostics Ltd. Methods of inhibiting rsk for treatment of breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4683700A (en) * 1999-04-30 2000-11-17 Beth Israel Deaconess Medical Center Decreasing adipose mass by altering rsk2 activity

Also Published As

Publication number Publication date
WO2003105766A2 (en) 2003-12-24
CA2488864A1 (en) 2003-12-24
AU2003251513A8 (en) 2003-12-31
EP1539781A4 (en) 2009-12-02
WO2003105766A3 (en) 2004-03-11
EP1539781A2 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
AU2003281736A1 (en) Electrodes and related devices
AU2003226094A1 (en) Compounds and methods
AU2003241833A1 (en) Beta-ALANINE DERIVATIVE AND USE THEREOF
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2003235956A1 (en) Quinazoline derivative and medicine
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003251513A1 (en) Rsk inhibitors and therapeutic uses thereof
AU2003243456A1 (en) Methods and devices for electrosurgery
AU2003298810A1 (en) NF-kB INHIBITORS AND USES THEREOF
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003245627A1 (en) Kinases and phosphatases
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003240052A1 (en) Il-11 derivatives and therapeutic uses thereof
AU2003287427A1 (en) Kinases and phosphatases
AU2003267790A1 (en) Lipase inhibitors and uses thereof
AU2003263329A1 (en) Foxp2 and uses thereof
AU2003262856A1 (en) Kinases and phosphatases
AUPS243002A0 (en) Therapeutic target and uses thereof
AU2003224331A1 (en) Insecticides and arachnicides
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2003231531A1 (en) Kinases and phosphatases